| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Dec 10, 2025 | Sell(S) | 556K | $23.37 | $13.0M | 3.9M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-26-000675) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for ArriVent BioPharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.